Biochemical biomarkers of oxidative collagen damage.

[en] Collagens are major constituents of connective tissues in the animal kingdom. During aging and inflammatory-related diseases, the collagen network undergoes oxidation that leads to structural and biochemical alterations within the collagen molecule. Collagen oxidation appears to be a key determinant of aging and a critical physiopathologic mechanism of numerous diseases. Further, the detection of oxidized-collagen peptides seems to be a promising approach for the diagnosis and the prognosis of inflammatory diseases. This chapter reviews the structural and biochemical changes to collagen induced by reactive oxygen and nitrogen species and discusses recent data on the use of collagen-derived biomarkers for measuring oxidative damage.

Disciplines :

Rheumatology

Author, co-author :

Henrotin, Yves ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.) - Didactique des sciences de la santé - Pathologie générale et physiopathologie

Deberg, Michelle ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)

Mathy, Marianne ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)

Deby-Dupont, G.

Language :

English

Title :

Biochemical biomarkers of oxidative collagen damage.

Publication date :

2009

Journal title :

Advances in Clinical Chemistry

ISSN :

0065-2423

Publisher :

Academic Press, New York, United States - New York

Volume :

Pages :

31-55

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 07 November 2010

Statistics

Number of views

92 (4 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

K. Gelse, E. Poschl, T. Aigner, Collagens-structure, function, and biosynthesis, Adv. Drug Deliv. Rev. 55 (12) (2003) 1531-1546.
R.J. Foltz, C.A. Piantadosi, J.D. Crapo, Oxygen toxicity, in: R.G. Crystal, J.B. West, P.J. Barnes, E.R. Weibel (Eds.), The Lung: Scientific Foundations, Lippincott-Raven, Philadelphia, 1997, pp. 2713-2722.
J.A. Knight, Free radicals: their history and current status in aging and disease, Ann. Clin. Lab. Sci. 28 (6) (1998) 331-346.
G. Deby-Dupont, C. Deby, M. Lamy, Oxygen therapy in intensive care patients: a vital poison? in: J.L. Vincent (Ed.), Yearbook of Intensive Care and Emergency Medicine, Springer Verlag, Berlin, 1999, pp. 417-432.
S. Cuzzocrea, et al., Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury, Pharmacol. Rev. 53 (1) (2001) 135-159.
W. Droge, Free radicals in the physiological control of cell function, Physiol. Rev. 82 (1) (2002) 47-95.
J.M. McCord, I. Fridovich, Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein), J. Biol. Chem. 244 (22) (1969) 6049-6055.
Y. Henrotin, B. Kurz, T. Aigner, Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthr. Cartil. 13 (8) (2005) 643-654.
Y.E. Henrotin, P. Bruckner, J.P. Pujol, The role of reactive oxygen species in homeostasis and degradation of cartilage, Osteoarthr. Cartil. 11 (10) (2003) 747-755.
D.B Zorov, et al., Reactive oxygen and nitrogen species: friends or foes? Biochemistry (Mosc) 70 (2) (2005) 215-221.
C. Deby, R. Goutier, New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases, Biochem. Pharmacol. 39 (3) (1990) 399-405.
J.S. Beckman, et al., Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. USA 87 (4) (1990) 1620-1624.
J.S. Beckman, Oxidative damage and tyrosine nitration from peroxynitrite, Chem. Res. Toxicol. 9 (5) (1996) 836-844.
A. Mouithys-Mickalad, et al., Peroxynitrite reacts with biological nitrogen-containing cyclic molecules by a radical pathway, as demonstrated by ultraweak luminescence coupled with ESR technique, Biochem. Biophys. Res. Commun. 259 (2) (1999) 460-464.
J.R. Lancaster Jr., K. Xie, Tumors faceNOproblems?Cancer Res. 66 (13) (2006) 6459-6462.
J.B. Sampson, et al., Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide, Arch. Biochem. Biophys. 356 (2) (1998) 207-213.
J.P. Eiserich, R.P. Patel, V.B. O'Donnell, Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules, Mol. Aspects Med. 19 (4-5) (1998) 221-357.
G. Deby-Dupont, C. Deby, M. Lamy, Neutrophil myeloperoxidase: effector of defense and host damage, in: J.L. Vincent (Ed.), Yearbook of Intensive Care and Emergency Medicine, Springer Verlag, Berlin, 1998, pp. 75-89.
G. Deby-Dupont, C. Deby, M. Lamy, Neutrophil myeloperoxidase revisited: its role in health and disease, Intensivmed (1999) 500-5013.
W.H. Koppenol, The Haber-Weiss cycle-70 years later, Redox Rep. 6 (4) (2001) 229-234.
D.P. Jones, Redefining oxidative stress, Antioxid. Redox Signal. 8 (9-10) (2006) 1865-1879.
B.M. Babior, NADPH oxidase: an update, Blood 93 (5) (1999) 1464-1476.
V.J. Thannickal, B.L. Fanburg, Reactive oxygen species in cell signaling, Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (6) (2000) L1005-L1028.
K.K. Griendling, D. Sorescu, M. Ushio-Fukai, NAD(P)H oxidase: role in cardiovascular biology and disease, Circ. Res. 86 (5) (2000) 494-501.
S. Milstien, Z. Katusic, Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function, Biochem. Biophys. Res. Commun. 263 (3) (1999) 681-684.
D.J. Stuehr, Mammalian nitric oxide synthases, Biochim. Biophys. Acta 1411 (2-3) (1999) 217-230.
S. Baldus, et al., Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase, Circulation 113 (15) (2006) 1871-1878.
Y.E. Henrotin, et al., Nitric oxide downregulates interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes, J. Rheumatol. 25 (8) (1998) 1595-1601.
P. Ghafourifar, E. Cadenas, Mitochondrial nitric oxide synthase, Trends Pharmacol. Sci. 26 (4) (2005) 190-195.
S.L. Hazen, et al., Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo, Circ. Res. 85 (10) (1999) 950-958.
C.J. van Dalen, et al., Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation, J. Biol. Chem. 275 (16) (2000) 11638-11644.
D. Lau, S. Baldus, Myeloperoxidase and its contributory role in inflammatory vascular disease, Pharmacol. Ther. 111 (1) (2006) 16-26.
M.L. Brennan, S.L. Hazen, Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment, Curr. Opin. Lipidol. 14 (4) (2003) 353-359.
M. Mathy-Hartert, et al., Bactericidal activity against Pseudomonas aeruginosa is acquired by cultured human monocyte-derived macrophages after uptake of myeloperoxidase, Experientia 52 (2) (1996) 167-174.
J.F. Turrens, Superoxide production by the mitochondrial respiratory chain, Biosci. Rep. 17 (1) (1997) 3-8.
M.L. Genova, et al., The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2, FEBS Lett. 505 (3) (2001) 364-368.
J.P. Bolanos, et al., Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases, J. Neurochem. 68 (6) (1997) 2227-2240.
T. Koeck, et al., Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria, J. Biol. Chem. 279 (26) (2004) 27257-27262.
B.F. McAdam, et al., Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation, J. Clin. Invest. 105 (10) (2000) 1473-1482.
D.M. Hockenbery, et al., Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell 75 (2) (1993) 241-251.
Y.J. Suzuki, H.J. Forman, A. Sevanian, Oxidants as stimulators of signal transduction, Free Radic. Biol. Med. 22 (1-2) (1997) 269-285.
J. Chandra, A. Samali, S. Orrenius, Triggering and modulation of apoptosis by oxidative stress, Free Radic. Biol. Med. 29 (3-4) (2000) 323-333.
J.F. Curtin, M. Donovan, T.G. Cotter, Regulation and measurement of oxidative stress in apoptosis, J. Immunol. Methods 265 (1-2) (2002) 49-72.
M. Ushio-Fukai, Redox signaling in angiogenesis: role of NADPH-oxidase, Cardiovasc. Res. 71 (2006) 226-235.
J. Cai, D.P. Jones, Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss, J. Biol. Chem. 273 (19) (1998) 11401-11404.
E.S. Arner, A. Holmgren, Physiological functions of thioredoxin and thioredoxin reductase, Eur. J. Biochem. 267 (20) (2000) 6102-6109.
A. Smolenski, et al., Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects, Naunyn Schmiedebergs Arch. Pharmacol. 358 (1) (1998) 134-139.
E. Linares, et al., Role of peroxynitrite in macrophage microbicidal mechanisms in vivo revealed by protein nitration and hydroxylation, Free Radic. Biol. Med. 30 (11) (2001) 1234-1242.
S. Magder, Reactive oxygen species: toxic molecules or spark of life? Crit. Care 10 (1) (2006) 208.
E. Crimi, et al., The role of oxidative stress in adult critical care, Free Radic. Biol. Med. 40 (3) (2006) 398-406.
A. Mouithys-Mickalad, et al., Oxygen consumption and electron spin resonance studies of free radical production by alveolar cells exposed to anoxia: inhibiting effects of the antibiotic ceftazidime, Redox Rep. 7 (2) (2002) 85-94.
S.H. Rezkalla, R.A. Kloner, No-reflow phenomenon, Circulation 105 (5) (2002) 656-662.
S.S. Sheu, D. Nauduri, M.W. Anders, Targeting antioxidants to mitochondria: a new therapeutic direction, Biochim. Biophys. Acta 1762 (2) (2006) 256-265.
G.A. Walford, et al., Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and-independent pathways, J. Biol. Chem. 279 (6) (2004) 4425-4432.
D.K. Das, R.M. Engelman, N. Maulik, Oxygen free radical signaling in ischemic preconditioning, Ann. N. Y. Acad. Sci. 874 (1999) 49-65.
A.P. Autor, A.C. Bonham, R.L. Thies, Toxicity of oxygen radicals in cultured pulmonary endothelial cells, J. Toxicol. Environ. Health 13 (2-3) (1984) 387-395.
A. Ahmad, et al., Endothelial Akt activation by hyperoxia: role in cell survival, Free Radic. Biol. Med. 40 (7) (2006) 1108-1118.
J.D. Crapo, et al., Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen, Am. Rev. Respir. Dis. 122 (1) (1980) 123-143.
L. Valgimigli, G.F. Pedulli, M. Paolini, Measurement of oxidative stress by EPR radicalprobe technique, Free Radic. Biol. Med. 31 (6) (2001) 708-716.
D.A. Svistunenko, et al., Mitochondrial dysfunction in patients with severe sepsis: an EPR interrogation of individual respiratory chain components, Biochim. Biophys. Acta 1757 (4) (2006) 262-272.
D. Pratico, et al., Formation of 8-iso-prostaglandin F2 alpha by human platelets, Agents Actions Suppl. 45 (1995) 27-31.
A Ben Baouali, et al., Plasma lipid peroxidation in critically ill patients: importance of mechanical ventilation, Free Radic. Biol. Med. 16 (2) (1994) 223-227.
Y. Henrotin, et al., Type II collagen peptides for measuring cartilage degradation, Biorheology 41 (3-4) (2004) 543-547.
M. Mathy-Hartert, et al., Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia, Eur. Respir. J. 16 (2) (2000) 296-301.
H. Buss, et al., Protein carbonyl measurement by a sensitive ELISA method, Free Radic. Biol. Med. 23 (3) (1997) 361-366.
I.S. Young, E.R. Trimble, Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection, Ann. Clin. Biochem. 28 (Pt. 5) (1991) 504-508.
J.D. Morrow, L.J. Roberts II, The isoprostanes. Current knowledge and directions for future research, Biochem. Pharmacol. 51 (1) (1996) 1-9.
H.H. Draper, M. Hadley, Malondialdehyde determination as index of lipid peroxidation, Methods Enzymol. 186 (1990) 421-431.
H. Esterbauer, K.H. Cheeseman, Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal, Methods Enzymol. 186 (1990) 407-421.
I. Rahman, F. Kelly, Biomarkers in breath condensate: a promising new non-invasive technique in free radical research, Free Radic. Res. 37 (12) (2003) 1253-1266.
J.C. Monboisse, J.P. Borel, Oxidative damage to collagen, Exs 62 (1992) 323-327.
H. Schuessler, K. Schilling, Oxygen effect in the radiolysis of proteins. Part 2. Bovine serum albumin, Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 45 (3) (1984) 267-281.
J.C. Monboisse, et al., Effect of oxy radicals on several types of collagen, Int. J. Tissue React. 6 (5) (1984) 385-390.
J.C. Monboisse, et al., Non-enzymatic degradation of acid-soluble calf skin collagen by superoxide ion: protective effect of flavonoids, Biochem. Pharmacol. 32 (1) (1983) 53-58.
V. Monboisse, et al., Nonisotopic evaluation of collagen in fibroblasts cultures, Anal. Biochem. 176 (2) (1989) 395-399.
K.M. Daumer, A.U. Khan, M.J. Steinbeck, Chlorination of pyridinium compounds. Possible role of hypochlorite, N-chloramines, and chlorine in the oxidation of pyridinoline cross-links of articular cartilage collagen type II during acute inflammation, J. Biol. Chem. 275 (44) (2000) 34681-34692.
J.M. Davies, D.A. Horwitz, K.J. Davies, Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis, Free Radic. Biol. Med. 15 (6) (1993) 637-643.
S. Olszowski, et al., Collagen type II modification by hypochlorite, Acta Biochim. Pol. 50 (2) (2003) 471-479.
K. Uchida, Y. Kato, S. Kawakishi, A novel mechanism for oxidative cleavage of prolyl peptides induced by the hydroxyl radical, Biochem. Biophys. Res. Commun. 169 (1) (1990) 265-271.
K. Wang, et al., Free radicals-induced abnormal chondrocytes, matrix and mineralization. A new concept of Kaschin-Beck's disease, Chin. Med. J. (Engl) 104 (4) (1991) 307-312.
J.R. Requena, et al., Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions, Nephrol. Dial. Transplant. 11 (Suppl. 5) (1996) 48-53.
K.N. Sulochana, et al., Glycation and glycoxidation studies in vitro on isolated human vitreous collagen, Med. Sci. Monit. 9 (6) (2003) BR220-BR224.
S.P. Wolff, R.T. Dean, Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes, Biochem. J. 245 (1) (1987) 243-250.
M.U. Ahmed, S.R. Thorpe, J.W. Baynes, Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein, J. Biol. Chem. 261 (11) (1986) 4889-4894.
K.V. Chace, R. Carubelli, R.E. Nordquist, The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates, Arch. Biochem. Biophys. 288 (2) (1991) 473-480.
G.B. Sajithlal, P. Chithra, G. Chandrakasan, An in vitro study on the role of metal catalyzed oxidation in glycation and crosslinking of collagen, Mol. Cell. Biochem. 194 (1-2) (1999) 257-263.
M.C. Wells-Knecht, S.R. Thorpe, J.W. Baynes, Pathways of formation of glycoxidation products during glycation of collagen, Biochemistry 34 (46) (1995) 15134-15141.
M.A. Glomb, V.M. Monnier, Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction, J. Biol. Chem. 270 (17) (1995) 10017-10026.
D.R. Sell, V.M. Monnier, Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue, Connect. Tissue Res. 19 (1) (1989) 77-92.
N. Verzijl, et al., Age-related accumulation of Maillard reaction products in human articular cartilage collagen, Biochem. J. 350 (Pt. 2) (2000) 381-387.
D.R. Sell, et al., Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia, Diabetes Metab. Rev. 7 (4) (1991) 239-251.
C.J. Hernandez, et al., Trabecular microfracture and the influence of pyridinium and nonenzymatic glycation-mediated collagen cross-links, Bone 37 (6) (2005) 825-832.
N. Verzijl, et al., Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover, Matrix Biol. 20 (7) (2001) 409-417.
X. Wang, et al., Age-related changes in the collagen network and toughness of bone, Bone 31 (1) (2002) 1-7.
S. Viguet-Carrin, et al., Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae, Bone (2006).
J.C. Monboisse, et al., In vitro glycoxidation alters the interactions between collagens and human polymorphonuclear leucocytes, Biochem. J. 350 (Pt. 3) (2000) 777-783.
S. Horiuchi, et al., Extra-and intracellular localization of advanced glycation endproducts in human atherosclerotic lesions, Nephrol. Dial. Transplant. 11 (Suppl. 5) (1996) 81-86.
H.M. Lander, et al., Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress, J. Biol. Chem. 272 (28) (1997) 17810-17814.
Y. Kaji, T. Oshika, [Role of advanced glycation end products and activation of PKC in diabetic retinopathy], Nippon Rinsho 63 (Suppl. 6) (2005) 188-193.
D.C. Paik, et al., Nitrite-induced cross-linking alters remodeling and mechanical properties of collagenous engineered tissues, Connect. Tissue Res. 47 (3) (2006) 163-176.
K. Horie, et al., Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy, J. Clin. Invest. 100 (12) (1997) 2995-3004.
D.R. Sell, et al., Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence, Proc. Natl. Acad. Sci. USA 93 (1) (1996) 485-490.
D.R. Sell, N.R. Kleinman, V.M. Monnier, Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice, FASEB J. 14 (1) (2000) 145-156.
V.M. Monnier, et al., Relation between complications of type I diabetes mellitus and collagen-linked fluorescence, N. Engl. J. Med. 314 (7) (1986) 403-408.
D.R. Sell, et al., Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM, Diabetes 41 (10) (1992) 1286-1292.
D.R. McCance, et al., Long-term glycemic control and neurological function in IDDM patients, Diabetes Care 16 (9) (1993) 1291-1293.
V.M. Monnier, et al., Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications, Diabetes 48 (4) (1999) 870-880. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
D.G. Dyer, et al., Accumulation of Maillard reaction products in skin collagen in diabetes and aging, J. Clin. Invest. 91 (6) (1993) 2463-2469.
S. Genuth, et al., Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes, Diabetes 54 (11) (2005) 3103-3111.
A. Maroudas, G. Palla, E. Gilav, Racemization of aspartic acid in human articular cartilage, Connect. Tissue Res. 28 (3) (1992) 161-169.
R.A. Bank, et al., Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage, Biochem. J. 330 (Pt. 1) (1998) 345-351.
J. DeGroot, et al., Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis, Arthritis Rheum. 50 (4) (2004) 1207-1215.